反応 #11695
ord-ca029937102741169ab21ba3db64bf5e
反応方程式
(S)—N-t-butyloxycarbonyl(2-aminomethylphenyl)alanine
N,N-dimethylformamide
1-hydroxy-7-azabenzotriazole
1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride
→
(S)-4-(t-butyloxycarbonylamino)-2,3,4,5-tetrahydro-2-benzazepin-3(1H)-one
反応物
試薬
なし
反応条件
詳細条件
See reaction.notes.procedure_details.
後処理
- 1その他The solvent was removed under vacuum
- 2workup.DISSOLUTIONthe residue was dissolved ethyl acetate (100 mL)
- 3洗浄This solution was washed sequentially with 1.0 M aqueous hydrochloric acid (50 mL twice), 1.0 M aqueous sodium hydroxide (50 mL), water (50 mL), and brine (50 mL)
- 4乾燥dried over anhydrous sodium sulfate
- 5その他evaporated under vacuum
実験手順
A mixture of (S)—N-t-butyloxycarbonyl(2-aminomethylphenyl)alanine (353 mg), N,N-dimethylformamide (10 mL), dichloromethane (50 mL), 1-hydroxy-7-azabenzotriazole (252 mg), and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (180 mg) was stirred at room temperature for 1 h. The solvent was removed under vacuum and the residue was dissolved ethyl acetate (100 mL). This solution was washed sequentially with 1.0 M aqueous hydrochloric acid (50 mL twice), 1.0 M aqueous sodium hydroxide (50 mL), water (50 mL), and brine (50 mL), dried over anhydrous sodium sulfate, and evaporated under vacuum to obtain (S)-4-(t-butyloxycarbonylamino)-2,3,4,5-tetrahydro-2-benzazepin-3(1H)-one (315 mg).